Edgewise Therapeutics Inc (EWTX) USD0.0001
0.52%- This stock can be held in a
Stocks and Shares ISASell:$14.74
Buy:$14.77
Change:
$0.38
(2.63%)
$0.38
(2.63%)Market closed | Prices delayed by at least 15 minutes
Sell:$14.74
Buy:$14.77
Change:$0.38
(2.63%)
$0.38
(2.63%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 May 2025 | Robert Michael CarruthersCFO | Sell Tax related | 1,314 | $16.45 | $21,620.82 | 81,014 |
| 2 May 2025 | Joanne M DonovanOther Level A | Sell Tax related | 5,187 | $16.45 | $85,347.94 | 21,588 |
| 2 May 2025 | Kevin KochPresident/CEO | Sell Tax related | 4,276 | $16.45 | $70,358.16 | 20,619 |
| 2 May 2025 | Behrad Mokhtar-DerakhshanChief Level Officer | Sell Tax related | 1,691 | $16.45 | $27,824.05 | 20,355 |
| 2 May 2025 | Alan J RussellPresident | Sell Tax related | 1,551 | $16.45 | $25,520.46 | 18,521 |
| 2 May 2025 | John R MooreGeneral Counsel | Sell Tax related | 1,930 | $16.45 | $31,756.61 | 6,531 |
| 3 April 2025 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 372,578 | $20.13 | $7,499,995.14 | 14,809,075 |
| 3 April 2025 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 124,193 | $20.13 | $2,500,005.09 | 443,792 |
| 7 March 2025 | Alan J RussellPresident | Sell Option/Award related | 200 | $30.02 | $6,004.00 | 14,863 |
| 7 March 2025 | Kevin KochPresident/CEO | Sell Option/Award related | 100 | $30.00 | $3,000.00 | 14,478 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 April 2025 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 372,578 | $20.13 | $7,499,995.14 | 14,809,075 |
| 30 December 2024 | Alan J RussellPresident | Sell Option/Award related | 100,000 | $27.37 | $2,737,470.00 | 14,863 |
| 3 April 2025 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 124,193 | $20.13 | $2,500,005.09 | 443,792 |
| 20 September 2024 | Alan J RussellPresident | Sell Option/Award related | 74,185 | $28.25 | $2,096,052.66 | 13,534 |
| 20 September 2024 | Robert Michael CarruthersCFO | Sell Option/Award related | 50,000 | $28.55 | $1,427,385.00 | 6,904 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.